Your browser doesn't support javascript.
loading
Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy.
Ben-Menachem, Elinor; Grebe, Hans Peter; Terada, Kiyohito; Jensen, Lori; Li, Ting; De Backer, Marc; Steiniger-Brach, Björn; Gasalla, Teresa; Brock, Melissa; Biton, Victor.
Afiliação
  • Ben-Menachem E; Institute for Clinical Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Grebe HP; Department of Neurology, Hospital São Sebastião, Centro Hospitalar de Entre o Douro e Vouga, Santa Maria da Feira, Portugal.
  • Terada K; NHO Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan.
  • Jensen L; UCB Pharma, Raleigh, NC, USA.
  • Li T; UCB Pharma, Raleigh, NC, USA.
  • De Backer M; UCB Pharma, Brussels, Belgium.
  • Steiniger-Brach B; UCB Pharma, Brussels, Belgium.
  • Gasalla T; UCB Pharma, Raleigh, NC, USA.
  • Brock M; UCB Pharma, Raleigh, NC, USA.
  • Biton V; Arkansas Epilepsy Program, Clinical Trials Inc, Little Rock, AR, USA.
Epilepsia ; 60(12): 2437-2447, 2019 12.
Article em En | MEDLINE | ID: mdl-31755090

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carbamazepina / Epilepsia / Lacosamida / Anticonvulsivantes Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carbamazepina / Epilepsia / Lacosamida / Anticonvulsivantes Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article